Anticoagulation

Study Seeks Patients For Blood Clot, Medication Studies

Published in Blood Weekly, August 9th, 2001

Doctors at the University of North Carolina at Chapel Hill (UNC) are seeking adults with acute pulmonary embolism or deep vein thrombosis to participate in studies aimed at improving treatments for blood clots.

Dr. Stephan Moll, director of the thrombophilia program at the UNC School of Medicine's Center for Thrombosis and Hemostasis, said the studies will help determine the best way to prevent blood clot recurrence. Coumadin, known generically as warfarin, is the standard blood-thinning medication doctors use to treat patients during the first six months after a blood clot is diagnosed, Moll said. However, the drug presents risks, and it topped UNC's recent list of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-08-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry